Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer

It is crucial to discover and develop reliable and robust biomarkers to specifically and sensitively pinpoint the patients that will benefit the most from adoptive cell therapy, as well as those that are at higher risk of developing potentially serious toxicities.